Pre-invasive disease of the lower genital tract

When you have completed this course you will be able to:

• describe the basic anatomy and histology of the cervix
• explain the concept of pre-invasive disease
• describe basic knowledge of the biology of human papillomavirus
• relate the role of human papillomavirus testing in the management of CIN
• recognise the benefit of screening for pre-invasive disease
• recall the treatment options for pre-invasive disease
• identify the benefits and limitations of immunisation against human papillomavirus disease

Dr Halima Alazzani (2023)

This course is intended to help clinicians gain core knowledge for O&G training and the MRCOG examinations.

National Institute of Clinical Excellence. Guidance on the Use of Liquid-Based Cytology for Cervical Screening. Technology Appraisal 69. NICE; 2003.

Royal College of Obstetricians and Gynaecologists. Progress in Cervical Screening in the UK. Scientific Impact Paper No. 7. London: RCOG; 2016.

Public Health England. Guidance: Cervical Screening. Programme and Colposcopy Management. London: PHE, 2021 [Accessed September 2022].

Morrison J, Baldwin P, Buckley L, Cogswell L, Edey K, Faruqi A et al. British Gynaecological Cancer Society (BGCS) Vulval Cancer Guidelines: Recommendations for Practice. May 2020. [Accessed October 2023] .

Gurumurthy M, Peevor R, Fiander A. Human papillomavirus update (including vaccination). Obstet Gynae Repod Med 2013;23:231–7.